Home > Galenea Salary

Galenea Salary

  • 30
  • 13
  • 35
Galenea average salary is $78,083, median salary is $78,083 with a salary range from $78,083 to $78,083.
Galenea salaries are collected from government agencies and companies. Each salary is associated with a real job position. Galenea salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
78,083
Average
78,083
Median
78,083
High
78,083
Total 1 Galenea Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Business Management Analyst 78,083-78,083 Piscataway, NJ, 08854 2012 Galenea Business Management Analyst Salaries (1)
Galenea Piscataway, NJ Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Galenea salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Galenea Jobs
See more Galenea Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
29

All Patents

7

Grant Patents

21

Patents Pending

8

Patents Families

More Recent
Galenea... Information
  • Galenea Corp.
  • Industry: BioTech/Drugs
  • City: Cambridge, MA
  • Galenea was founded on the ground-breaking work of Professors Susumu Tonegawa at the Massachusetts Institute of Technology and Maria Karayiorgou at Columbia University Medical Center (formerly at The Rockefeller University). Together, their laboratories obtained both behavioral and genetic evidence for the role of calcineurin in the pathogenesis of schizophrenia. This advance suggests that the calcineurin pathway is a potential untapped source of therapeutic targets for the development of mechanism-based treatments for the disease. With the goal of generating new therapeutics with a particular focus on the associated memory and cognition impairments characteristic of schizophrenia and related disorders, Galenea established a